Our group has earlier shown that G-CSF reduces the disease severity, delays the mortality of severe alcoholic hepatitis (SAH) patients (16), and mobilizes bone marrow-derived CD34+ cells in acute-on-chronic liver failure (ACLF) patients for hepatic regeneration (17). This evidence concerns the gene CSF3 and chronic liver failure.